×
About 55,586 results

ALLMedicine™ Systemic Lupus Erythematosus Center

Research & Reviews  26,397 results

Prevention of infective complications in systemic lupus erythematosus: A systematic lit...
https://doi.org/10.1111/1756-185X.14125
International Journal of Rheumatic Diseases; Oku K, Hamijoyo L et. al.

May 17th, 2021 - Systemic lupus erythematosus (SLE) is a more common autoimmune rheumatic disease in the Asia-Pacific region. The prognosis of SLE remains unsatisfactory in some Asian countries because of delayed diagnosis, limited access to medications, increased...

Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disea...
https://doi.org/10.1177/09612033211016100
Lupus Soliman SA, Haque A et. al.

May 15th, 2021 - To evaluate the performance of 4 plasma protein markers for detecting disease activity in childhood-onset systemic lupus erythematosus (SLE) patients. Eighty-three consecutive pediatric patients fulfilling ≥4 ACR criteria for SLE and twenty-five h...

Value of second-trimester uterine artery pulsatility index in pregnancies with systemic...
https://doi.org/10.1080/14767058.2021.1918090
The Journal of Maternal-fetal & Neonatal Medicine : the O... Canto MJ, Ortiz-Santamaria V et. al.

May 13th, 2021 - To assess the value of the second trimester mean pulsatility index of the uterine arteries (MPI-UtA) to predict adverse perinatal outcome (APO) in women with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Pregnancies wi...

Estrogen-induced hsa-miR-10b-5p is elevated in T cells from patients with systemic lupu...
https://doi.org/10.1002/art.41787
Arthritis & Rheumatology (Hoboken, N.J.); Ramanujan SA, Cravens EN et. al.

May 13th, 2021 - Autoimmune diseases afflict women disproportionately more than men. Estrogen is implicated in immune cell dysfunction, yet its precise molecular roles are not fully known. We recently uncovered new roles for serine/arginine-rich splicing factor (S...

Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hy...
https://doi.org/10.1002/art.41801
Arthritis & Rheumatology (Hoboken, N.J.); Feldman CH, Link MS

May 13th, 2021 - Hydroxychloroquine (HCQ), an antimalarial agent, was first approved by the U.S. Food and Drug Administration for the treatment of rheumatic diseases in 1955 and has since become a crucial disease-modifying antirheumatic drug (DMARD). It is now a s...

see more →

Guidelines  87 results

ACR Convergence 2020: Study Data for Lupus & Rheumatoid Arthritis
https://www.the-rheumatologist.org/article/acr-convergence-2020-study-data-for-lupus-rheumatoid-arthritis/
The Rheumatologist; Hickman RJ.

Nov 8th, 2020 - At the annual meeting’s second Plenary Session, Saturday, Nov. 7, speakers highlighted phase 2 results of a potential new biologic for systemic lupus erythematosus (SLE), as well as data on remission maintenance in rheumatoid arthritis (RA) after ...

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
https://pubmed.ncbi.nlm.nih.gov/33154498/
Scientific Reports; Cohen IV, Makunts T et. al.

Nov 4th, 2020 - Chloroquine (CQ) and hydroxychloroquine (HCQ) are on the World Health Organization's List of Essential Medications for treating non-resistant malaria, rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). In addition, both drugs are cu...

Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557711/
Cureus Shah L

Oct 11th, 2020 - Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. Rheumatoid arthritis mainly consists of distal symmetrical deforming polyarthritis. SLE patients have immune compl...

Fasting Triglycerides & Glucose Index: A Useful Screening Test for Assessing Insulin Resistance in Patients Diagnosed with Rheumatoid Arthritis & Systemic Lupus Erythematosus
https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-019-0495-x
Diabetology & Metabolic Syndrome; Contreras-Haro B,et al

Nov 26th, 2019 - Insulin resistance (IR) is frequently observed in patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). In clinical practice, IR assessment is limited to a low proportion of patients due to cost and equipment and technical...

Sjögren’s Syndrome in Systemic Lupus Erythematosus - a Subset Characterized by a Systemic Inflammatory State
http://www.jrheum.org/content/early/2019/09/11/jrheum.190250
J Rheumatology; Ruacho G,et al

Sep 20th, 2019 - Secondary Sjögren’s syndrome (SLE-sSS) is an often-neglected subset of patients with Systemic lupus erythematosus (SLE). Furthermore, primary Sjögren’s syndrome overlaps and can be difficult to delineate from SLE. To shed light on the SLE-sSS subs...

see more →

Drugs  29 results see all →

Clinicaltrials.gov  27,373 results

Prevention of infective complications in systemic lupus erythematosus: A systematic lit...
https://doi.org/10.1111/1756-185X.14125
International Journal of Rheumatic Diseases; Oku K, Hamijoyo L et. al.

May 17th, 2021 - Systemic lupus erythematosus (SLE) is a more common autoimmune rheumatic disease in the Asia-Pacific region. The prognosis of SLE remains unsatisfactory in some Asian countries because of delayed diagnosis, limited access to medications, increased...

Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disea...
https://doi.org/10.1177/09612033211016100
Lupus Soliman SA, Haque A et. al.

May 15th, 2021 - To evaluate the performance of 4 plasma protein markers for detecting disease activity in childhood-onset systemic lupus erythematosus (SLE) patients. Eighty-three consecutive pediatric patients fulfilling ≥4 ACR criteria for SLE and twenty-five h...

Value of second-trimester uterine artery pulsatility index in pregnancies with systemic...
https://doi.org/10.1080/14767058.2021.1918090
The Journal of Maternal-fetal & Neonatal Medicine : the O... Canto MJ, Ortiz-Santamaria V et. al.

May 13th, 2021 - To assess the value of the second trimester mean pulsatility index of the uterine arteries (MPI-UtA) to predict adverse perinatal outcome (APO) in women with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Pregnancies wi...

Estrogen-induced hsa-miR-10b-5p is elevated in T cells from patients with systemic lupu...
https://doi.org/10.1002/art.41787
Arthritis & Rheumatology (Hoboken, N.J.); Ramanujan SA, Cravens EN et. al.

May 13th, 2021 - Autoimmune diseases afflict women disproportionately more than men. Estrogen is implicated in immune cell dysfunction, yet its precise molecular roles are not fully known. We recently uncovered new roles for serine/arginine-rich splicing factor (S...

Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hy...
https://doi.org/10.1002/art.41801
Arthritis & Rheumatology (Hoboken, N.J.); Feldman CH, Link MS

May 13th, 2021 - Hydroxychloroquine (HCQ), an antimalarial agent, was first approved by the U.S. Food and Drug Administration for the treatment of rheumatic diseases in 1955 and has since become a crucial disease-modifying antirheumatic drug (DMARD). It is now a s...

see more →

News  1,687 results

Rituximab Benefits Seen in Neuropsychiatric Lupus
https://www.medscape.com/viewarticle/950242

Apr 28th, 2021 - Patients with neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) seem to benefit from rituximab (Rituxan) therapy, according to data from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR). Indeed, the perc...

Relapsing Lupus Nephritis and Cutaneous Vasculitis: A Race to Contain B Cells
https://www.medscape.com/viewarticle/949863

Apr 27th, 2021 - This article originally appeared on the Hospital for Special Surgery's website. Case Report A 45-year-old woman with a history of systemic lupus erythematosus (SLE) since 2006 came to the Hospital for Special Surgery in 2014 for continued manageme...

Renal, Cardiovascular Damage May Develop in Mild SLE Despite Treatment
https://www.medscape.com/viewarticle/949415

Apr 15th, 2021 - Patients with mild to moderate systemic lupus erythematosus (SLE) disease activity without any past history of organ damage may still progress to develop damage, particularly renal and cardiovascular disease, or death, in a relatively short amount...

COVID-19's Impact on Lupus Inpatients Examined in Study
https://www.medscape.com/viewarticle/948123

Mar 24th, 2021 - Severe COVID-19 infection was more likely in hospitalized patients with systemic lupus erythematosus (SLE) who had comorbidities and risk factors associated with severe infection in the general population, notably older age, male gender, and hyper...

Acute Infection Affects Lupus Patients in First Decade of Disease
https://www.medscape.com/viewarticle/947360

Mar 11th, 2021 - People with systemic lupus erythematosus (SLE) experienced significantly higher rates of first severe infections, a higher number of severe infections overall, and greater infection-related mortality, compared with controls, based on data from a p...

see more →

Patient Education  13 results see all →